Can a PEGylated protein be ever considered a Biosimilar drug?
In March 2015, the FDA approved the first biosimilar drug for use in the United States. The drug called Zarxio, produced by Sandoz, is used to help prevent infections in cancer patients receiving chemotherapy, and it is a biosimilar alternative to an existing protein biologic drug called Neupogen made by Amgen. In reviewing the FDA’s […]